BackInterpace Biosciences Overview
Interpace Biosciences, Inc.

Interpace Biosciences Discounted Cash Flow

DCF Analysis for IDXG.

Get informed when a big investor buys or sells

+ Follow

Fair Value

$-0.85

Current Fair Value

$-0.85
151.2% Downside

Overvalued by 151.2% based on the discounted cash flow analysis.

Average Upside/Downside (Comparison Companies)

Loading

Fair Value vs. Stock Price History

Loading

Upside/Downside History

Loading

Upside/Downside Comparison

Loading